Skip to Content
  1. All products
  2. Weight Management
  3. Semaglutide
  4. Weight Management
Pricelist: Default Pricelist Pricelist
Pricelist: Default Pricelist Pricelist
Semaglutide

Semaglutide

Lyophilized Vial · Subcutaneous Refrigerate 2–8°C · 18-month shelf life 99% Purity · USP Grade
99% Purity
PHYSICIAN USE ONLY
$ 75.00 $ 75.00

Format
💉 vial
  • Strength
Add to cart
Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days
Clinical Description

Weight management, appetite regulation, blood sugar control, insulin level regulation, fat loss while preserving lean mass

Semaglutide es un agonista del receptor GLP-1 que imita la hormona incretina natural del cuerpo para ayudar a regular el apetito, el azúcar en sangre y los niveles de insulina. Se usa ampliamente para el control del peso y la salud metabólica debido a su capacidad para reducir el hambre, retardar el vaciado gástrico y favorecer la pérdida de grasa mientras se preserva la masa magra.

Clinical Indications
Obesity / Weight LossType 2 DiabetesMetabolic SyndromeNASH/NAFLDCardiovascular Risk Reduction
Recommended Stacking Protocols
✓
Cagrilintide
For added appetite suppression
✓
KPV
Anti-inflammatory and gut protective support
✓
Tirzepatide
Dual agonist for enhanced effect (in rotation)

Mechanism of Action - Weight Management / Metabolic Pathway

GLP-1 Receptor Agonism
Binds GLP-1 receptors with high affinity, mimicking natural incretin action with extended half-life.
Appetite Suppression
Engages hypothalamic satiety centers to reduce hunger and promote caloric restriction.
Insulin Sensitization
Enhances glucose-dependent insulin release and reduces fasting glucagon.
Gastric Motility Reduction
Slows gastric emptying to extend satiety and reduce postprandial glucose spikes.
Starting Dose
0.25mg once weekly
Initiation phase for tolerance and baseline response.
Titration
Increase gradually by 0.25-0.5mg every 2-4 weeks
Maintenance Range
1mg-2.5mg per week
Adjust based on objective outcomes and physician review.
Suggested Dosing Notes

Dosis inicial:0,25 mg una vez a la semana

Valoración:Aumentar gradualmente en 0,25-0,5 mg cada 2-4 semanas

Rango de mantenimiento típico:1 mg-2,5 mg por semana

Period Dose Phase Clinical Notes
Starting Dose 0.25mg once weekly initiation Initial dose for treatment initiation
Titration Increase by 0.25-0.5mg every 2-4 weeks escalation Gradual increase as tolerated
Maintenance Range 1mg-2.5mg per week maintenance Typical maintenance dose range
Week 13+ 1.0–2.0 mg maintenance Individualize. Max clinical dose 2.4 mg/week.
Preparation Protocol
  1. Semaglutide se suministra como polvo liofilizado.
  2. Semaglutide debe reconstituirse con agua bacteriostática antes de su uso.
  3. Elija el volumen de reconstitución según el tamaño del vial para facilitar la dosificación.
1
Lyophilized Powder
Semaglutide is supplied as a lyophilized powder.
2
Reconstitution Required
Semaglutide must be reconstituted with Bacteriostatic Water before use.
3
Choose Volume
Choose your reconstitution volume based on the vial size for easy dosing.
4
Reconstitute the Vial
Wipe stopper with alcohol swab. Inject BW slowly along the glass wall — never directly onto the powder. Allow liquid to run down the sides.
⚠️ Do not shake. Gently swirl or roll between palms (30–60 sec). Shaking causes irreversible peptide degradation.
5
Inspect & Store
Solution should be clear and colorless or slightly yellow. Discard if cloudy or particulate. Store reconstituted at 2–8°C, use within 28 days. Label with date.
Reconstitution & Dosing Guide
Standard 1 mL insulin syringe: 100 units = 1 mL

Total Peptide: 5 mg
BW: 1 mL
Concentration: 5mg/mL (50mcg per unit)
Dose Units to Draw Volume (mL) Approx. Supply
0.25mg 5 units - 20 weeks
0.5mg 10 units - 10 weeks
0.75mg 15 units - 6-7 weeks
1mg 20 units - 5 weeks
1.25mg 25 units - 4 weeks
1.5mg 30 units - 3 weeks
1.75mg 35 units - 3 weeks
2mg 40 units - 2.5 weeks
2.5mg 50 units - 2 weeks
Identity
  • Name: Semaglutide
  • Product Type: Vial | Subcutaneous Injection
  • CAS Number: 910463-68-2
  • Available Strengths: 5mg, 10mg, 15mg, 20mg, 30mg
  • Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
  • Molecular Weight: 4,113.6 Da
  • Sequence / Type: GLP-1 Receptor Agonist
  • Available Strengths: 5mg, 10mg, 15mg, 20mg, 30mg, 100mg
Quality & Purity
  • Purity: 99%+
  • Purity: ≥ 99%
  • Endotoxin: ≤ 1 EU/mg
  • Appearance: White lyophilized powder
  • Solubility: Bacteriostatic water
Storage & Handling
  • Storage: Refrigerate after reconstitution (2-8°C)
  • Pre-use Storage: -20°C (long-term) / 2–8°C (short)
  • Post-Reconstitution: 2–8°C · Up to 28 days
  • Shelf Life: 18 months from manufacture

Timing: Use consistent administration timing for stable protocol tracking.

Storage: Refrigerate 2–8°C · 18-month shelf life

Frequency: StartingDose:O.25mg onceweekly

Cycle: Titration:Increasegraduallyby0.25-0.5mgevery2-4weeks

Injection Sites: Rotate approved injection sites to reduce local irritation risk.